HomeSouth Korea: SunBio raises around US$4.8m through issuance of new shares in...

South Korea: SunBio raises around US$4.8m through issuance of new shares in Korea

-

SunBio, a biotech company developing biosimilars, biopharmaceuticals, and medical devices based on its proprietary technologies of pegylation, has issued new shares through a general Initial Public Offering for listing on the KOSDAQ stock…

Subscription required

This content is for Subscribers only. To access 4,800+ articles from an archive of 7 years plus data tables on M&A, Equity, Debt and more

Already have an account?
Nick Herbert
Nick Herbert
Nick Herbert has over 30 years’ experience in the financial markets, as both a practitioner and journalist. He started work as an investment banker in London, before joining International Financing Review (IFR) to report on debt capital markets and derivatives. He moved to Singapore in 2000 to manage IFR’s financial markets editorial team throughout Asia, before returning to London in 2009 to take up the position of Publisher for Reuters Capital Markets Publications. For the last five years he has been covering global capital markets, ESG finance and healthcare markets on a freelance basis.
Related Articles
More From Author

Subscription required

This content is for Subscribers only. To access 4,800+ articles from an archive of 7 years plus data tables on M&A, Equity, Debt and more

Already have an account?

Subscription required

This content is for Subscribers only. To access 4,800+ articles from an archive of 7 years plus data tables on M&A, Equity, Debt and more

Already have an account?
Advertisement

Related Resources

Related Events